These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 12825457

  • 1. Recent advances and new directions in the discovery and development of cyclin-dependent kinase inhibitors.
    Fischer PM.
    Curr Opin Drug Discov Devel; 2001 Sep; 4(5):623-34. PubMed ID: 12825457
    [Abstract] [Full Text] [Related]

  • 2. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M, Gortat A, Mondragón L, Bachs O, Pérez-Payá E.
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of chemotherapy-induced alopecia by cyclin-dependant kinase inhibitors].
    Meijer L, Knockaert M, Damiens E.
    Bull Cancer; 2001 Apr; 88(4):347-50. PubMed ID: 11371368
    [Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
    Kaubisch A, Schwartz GK.
    Cancer J; 2000 Apr; 6(4):192-212. PubMed ID: 11038138
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyclin-dependent kinase inhibitors: novel anticancer agents.
    Mani S, Wang C, Wu K, Francis R, Pestell R.
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1849-70. PubMed ID: 11060782
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclin-dependent kinase modulators: a novel class of cell cycle regulators for cancer therapy.
    Senderowicz AM.
    Cancer Chemother Biol Response Modif; 2001 Aug; 19():165-88. PubMed ID: 11686013
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CDK inhibitors in cancer therapy: what is next?
    Malumbres M, Pevarello P, Barbacid M, Bischoff JR.
    Trends Pharmacol Sci; 2008 Jan; 29(1):16-21. PubMed ID: 18054800
    [Abstract] [Full Text] [Related]

  • 12. Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
    Finlay MR, Acton DG, Andrews DM, Barker AJ, Dennis M, Fisher E, Graham MA, Green CP, Heaton DW, Karoutchi G, Loddick SA, Morgentin R, Roberts A, Tucker JA, Weir HM.
    Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4442-6. PubMed ID: 18617397
    [Abstract] [Full Text] [Related]

  • 13. Structure-based discovery and optimization of potential cancer therapeutics targeting the cell cycle.
    Thomas MP, McInnes C.
    IDrugs; 2006 Apr 01; 9(4):273-8. PubMed ID: 16596481
    [Abstract] [Full Text] [Related]

  • 14. Small molecules as inhibitors of cyclin-dependent kinases.
    Huwe A, Mazitschek R, Giannis A.
    Angew Chem Int Ed Engl; 2003 May 16; 42(19):2122-38. PubMed ID: 12761741
    [Abstract] [Full Text] [Related]

  • 15. [Chemical inhibitors of cyclic-dependent kinases: preclinical and clinical study].
    Damiens E, Meijer L.
    Pathol Biol (Paris); 2000 Apr 16; 48(3):340-51. PubMed ID: 10858966
    [Abstract] [Full Text] [Related]

  • 16. 3-Acyl-2,6-diaminopyridines as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
    Lin R, Lu Y, Wetter SK, Connolly PJ, Turchi IJ, Murray WV, Emanuel SL, Gruninger RH, Fuentes-Pesquera AR, Adams M, Pandey N, Moreno-Mazza S, Middleton SA, Jolliffe LK.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2221-4. PubMed ID: 15837297
    [Abstract] [Full Text] [Related]

  • 17. Coming full circle: cyclin-dependent kinases as anti-cancer drug targets.
    Fisher RP.
    Subcell Biochem; 2010 May 02; 50():1-15. PubMed ID: 20012574
    [Abstract] [Full Text] [Related]

  • 18. A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors.
    Bhattacharjee AK, Geyer JA, Woodard CL, Kathcart AK, Nichols DA, Prigge ST, Li Z, Mott BT, Waters NC.
    J Med Chem; 2004 Oct 21; 47(22):5418-26. PubMed ID: 15481979
    [Abstract] [Full Text] [Related]

  • 19. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine.
    Song Y, Kesuma D, Wang J, Deng Y, Duan J, Wang JH, Qi RZ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):128-32. PubMed ID: 15047157
    [Abstract] [Full Text] [Related]

  • 20. [Development of new antitumor reagents which block the cell cycle progression].
    Osada H.
    Gan To Kagaku Ryoho; 1997 Sep 23; 24(11):1541-6. PubMed ID: 9309153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.